VanEck Pharmaceutical ETF
PPH
PPH
48 hedge funds and large institutions have $136M invested in VanEck Pharmaceutical ETF in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
30% less call options, than puts
Call options by funds: $312K | Put options by funds: $445K
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Holders
48
Holding in Top 10
–
Calls
$312K
Puts
$445K
Top Buyers
| 1 | +$66.5M | |
| 2 | +$5.78M | |
| 3 | +$1.27M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$862K |
| 5 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$436K |
Top Sellers
| 1 | -$2.47M | |
| 2 | -$1.62M | |
| 3 | -$922K | |
| 4 |
SB
Suntrust Banks
Atlanta,
Georgia
|
-$696K |
| 5 |
VF
Virtu Financial
New York
|
-$581K |